• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

精制疑似戊聚糖多硫酸钠性视网膜病变患者的视网膜表型。

REFINING THE RETINAL PHENOTYPE OF PATIENTS WITH SUSPECTED PENTOSAN POLYSULFATE SODIUM RETINOPATHY.

机构信息

Jacobs Retina Center, University of California San Diego, La Jolla, California, United States of America.

Shiley Eye Institute, University of California San Diego, La Jolla, California, United States of America; and.

出版信息

Retina. 2023 Sep 1;43(9):1472-1479. doi: 10.1097/IAE.0000000000003844.

DOI:10.1097/IAE.0000000000003844
PMID:37229759
Abstract

PURPOSE

To refine the retinal phenotypes of suspected pentosan polysulfate sodium toxicity using ultra-widefield imaging.

METHODS

Patients with complete dosing profiles who visited the ophthalmology department and with ultra-widefield and optical coherence tomography imaging records were identified using electronic health records at a large academic center. Retinal toxicity was initially identified using previously published imaging criteria, while grading was categorized using both previously reported and new classification systems.

RESULTS

One hundred and four patients were included in this study. Twenty-six (25%) were identified as having toxicity from PPS. The mean duration of exposure and cumulative dose between the retinopathy group (162.7 months, 1,803.2 g) were longer and higher compared with the nonretinopathy group (69.7 months, 972.6 g) (both P < 0.001). There was variability of extramacular phenotype in the retinopathy group, with four eyes having only peripapillary involvement and six eyes having far peripheral extension.

CONCLUSION

Retinal toxicity in the setting of prolonged exposure and increased cumulative dosing from PPS therapy produces phenotypic variability. Providers should be aware of the extramacular component of toxicity when screening patients. Understanding the different retinal phenotypes may prevent continued exposure and reduce the risk of vision-threatening foveal-involving disease.

摘要

目的

利用超广角成像技术完善对疑似聚戊烯硫酸钠毒性的视网膜表型。

方法

通过电子病历,在一个大型学术中心,鉴定出有完整用药记录且有超广角和光相干断层扫描成像记录的眼科就诊患者。最初使用已发表的成像标准来识别视网膜毒性,同时使用已报道和新的分类系统进行分级。

结果

本研究共纳入 104 例患者。26 例(25%)被确定为 PPS 毒性。与非视网膜病变组相比,视网膜病变组的暴露时间(162.7 个月)和累积剂量(1803.2g)更长、更高(均 P < 0.001)。视网膜病变组的周边外表型存在差异,4 只眼仅累及视盘周围,6 只眼有远周边延伸。

结论

PPS 治疗的长时间暴露和累积剂量增加会导致视网膜毒性出现表型变化。在筛查患者时,临床医生应注意毒性的周边外表现。了解不同的视网膜表型可以防止持续暴露,并降低威胁视力的黄斑受累疾病的风险。

相似文献

1
REFINING THE RETINAL PHENOTYPE OF PATIENTS WITH SUSPECTED PENTOSAN POLYSULFATE SODIUM RETINOPATHY.精制疑似戊聚糖多硫酸钠性视网膜病变患者的视网膜表型。
Retina. 2023 Sep 1;43(9):1472-1479. doi: 10.1097/IAE.0000000000003844.
2
Redefining the Spectrum of Pentosan Polysulfate Retinopathy: Multimodal Imaging Findings from a Cross-Sectional Screening Study.重新定义戊聚糖多硫酸酯视网膜病变的范围:一项横断面筛查研究的多模态成像结果。
Ophthalmol Retina. 2022 Sep;6(9):835-846. doi: 10.1016/j.oret.2022.03.016. Epub 2022 Mar 24.
3
RAPID PENTOSAN POLYSULFATE SODIUM MACULOPATHY PROGRESSION.快速戊聚糖多硫酸钠黄斑病变进展。
Retin Cases Brief Rep. 2023 Nov 1;17(6):660-663. doi: 10.1097/ICB.0000000000001273.
4
RETINAL STRUCTURAL CHANGES AFTER CESSATION OF PENTOSAN POLYSULFATE SODIUM.戊聚糖硫酸钠停药后的视网膜结构变化。
Retina. 2024 Nov 1;44(11):1976-1982. doi: 10.1097/IAE.0000000000004197.
5
NINE-YEAR PROGRESSION OF PENTOSAN MACULOPATHY WITH MULTIMODAL RETINAL IMAGING.九年内窥镜下评估五倍子治疗黄斑病变的进展。
Retin Cases Brief Rep. 2023 Nov 1;17(6):664-667. doi: 10.1097/ICB.0000000000001276.
6
Pentosan Polysulfate Sodium-Associated Maculopathy: Early Detection Using OCT Angiography and Choriocapillaris Flow Deficit Analysis.戊聚糖多硫酸钠相关性脉络膜病变:应用 OCT 血管造影和脉络膜毛细血管血流缺损分析的早期检测。
Am J Ophthalmol. 2022 Dec;244:38-47. doi: 10.1016/j.ajo.2022.07.015. Epub 2022 Jul 25.
7
Pentosan Polysulfate Maculopathy: Prevalence, Spectrum of Disease, and Choroidal Imaging Analysis Based on Prospective Screening.聚戊烯多硫酸酯斑病变:基于前瞻性筛查的患病率、疾病谱和脉络膜成像分析。
Am J Ophthalmol. 2021 Jul;227:125-138. doi: 10.1016/j.ajo.2021.02.025. Epub 2021 Feb 27.
8
Disease Course in Patients With Pentosan Polysulfate Sodium-Associated Maculopathy After Drug Cessation.戊聚糖多硫酸钠相关性黄斑病变患者停药后的疾病进程。
JAMA Ophthalmol. 2020 Aug 1;138(8):894-900. doi: 10.1001/jamaophthalmol.2020.2349.
9
MACULAR HOLE IN A PATIENT WITH PENTOSAN POLYSULFATE MACULOPATHY.患有戊聚糖多硫酸酯黄斑病变的患者的黄斑裂孔。
Retin Cases Brief Rep. 2024 Sep 1;18(5):544-548. doi: 10.1097/ICB.0000000000001444.
10
Pentosan polysulfate sodium maculopathy: Final analysis of a prospective cohort, updated review, and association with inflammatory bowel disease.聚硫酸戊聚糖钠黄斑病变:一项前瞻性队列的最终分析、最新综述以及与炎症性肠病的关联
Surv Ophthalmol. 2025 May-Jun;70(3):583-592. doi: 10.1016/j.survophthal.2024.12.002. Epub 2024 Dec 12.